These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 22418032)
1. Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β. Jun S; Ochoa-Repáraz J; Zlotkowska D; Hoyt T; Pascual DW J Neuroimmunol; 2012 Apr; 245(1-2):39-47. PubMed ID: 22418032 [TBL] [Abstract][Full Text] [Related]
2. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518 [TBL] [Abstract][Full Text] [Related]
3. Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. Selvaraj RK; Geiger TL J Immunol; 2008 Mar; 180(5):2830-8. PubMed ID: 18292504 [TBL] [Abstract][Full Text] [Related]
4. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711 [TBL] [Abstract][Full Text] [Related]
5. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. Ochoa-Repáraz J; Rynda A; Ascón MA; Yang X; Kochetkova I; Riccardi C; Callis G; Trunkle T; Pascual DW J Immunol; 2008 Jul; 181(2):954-68. PubMed ID: 18606647 [TBL] [Abstract][Full Text] [Related]
6. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. Ochoa-Repáraz J; Riccardi C; Rynda A; Jun S; Callis G; Pascual DW J Immunol; 2007 Feb; 178(3):1791-9. PubMed ID: 17237429 [TBL] [Abstract][Full Text] [Related]
7. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis. Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998 [TBL] [Abstract][Full Text] [Related]
8. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis. Sun JB; Czerkinsky C; Holmgren J J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081 [TBL] [Abstract][Full Text] [Related]
10. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. Zhang H; Podojil JR; Chang J; Luo X; Miller SD J Immunol; 2010 Jun; 184(12):6629-36. PubMed ID: 20483764 [TBL] [Abstract][Full Text] [Related]
11. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610 [TBL] [Abstract][Full Text] [Related]
12. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells. Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002 [TBL] [Abstract][Full Text] [Related]
13. Active suppression induced by repetitive self-epitopes protects against EAE development. Puentes F; Dickhaut K; Hofstätter M; Falk K; Rötzschke O PLoS One; 2013; 8(5):e64888. PubMed ID: 23738007 [TBL] [Abstract][Full Text] [Related]
14. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction. Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181 [TBL] [Abstract][Full Text] [Related]
15. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. Mann MK; Maresz K; Shriver LP; Tan Y; Dittel BN J Immunol; 2007 Mar; 178(6):3447-56. PubMed ID: 17339439 [TBL] [Abstract][Full Text] [Related]
16. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353 [TBL] [Abstract][Full Text] [Related]
17. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. Carrier Y; Yuan J; Kuchroo VK; Weiner HL J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553 [TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen. Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028 [TBL] [Abstract][Full Text] [Related]